The current standard of care in the management of early-stage breast cancer is breast-conserving surgery followed by adjuvant whole-breast radiation therapy. More recently, there has been growing interest in accelerated partial breast irradiation (APBI) in the treatment of unifocal, early-stage breast cancers. This approach stemmed from the observation that more than 90% of ipsilateral Table 1 . [5] [6] [7] [8] [9] The guidelines range from the most discriminating ASTRO consensus guidelines to the more liberal ABS and ASBS guidelines. We performed a retrospective review of 347 consecutive primary breast cancer patients who underwent a preoperative breast MRI at our institution between January 2012 and December 2015. The number of patients meeting the inclusion criteria for each of the 5 consensus guidelines after conventional-imaging assessment was determined and compared. We then evaluated the utility of MRI in identifying additional mammographically occult disease for each selected cohort.
The schema of our study is presented in Figure 1 .
The median age of our patient cohort was 56 (range: 44-68 Our study showed that the ASTRO guidelines were statistically more selective than the guidelines by the GEC-ESTRO, ABS, and ASBS. Several different clinical and pathologic features have been associated with higher rates of mammographically occult disease. In their review, Di Leo et al found that invasive lobular histology, as well as premenopausal status and size ≥2 cm, was all predictors for APBI ineligibility after MRI. 10 In our study, invasive lobular histology was the only feature that remained predictive of mammographically occult disease on multivariate analysis. We observed the highest rate of mammographically occult disease in patients selected by the ABS guidelines, the only guideline to allow for ILC. Given the higher rates of multifocal disease and increased predilection for regional lymph node spread, the inclusion of ILC for APBI remains controversial.
Overall, we describe a significant trend demonstrating an increased utility of preoperative MRI in patients eligible for APBI by less selective APBI guidelines (P = 0.04). This is the same phenomenon described by Di Leo et al whereby there was a significant negative correlation between ineligibility for APBI at conventional assessment and subsequent ineligibility by MRI they call the "compensation effect." 10 Further maturation of current APBI trials as well as additional studies to better stratify women by clinicopathologic and biologic factors will be important to optimize patient selection for APBI.
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